Doctor profile · Federal record

Dr. Matthew Lambiase, D.O.

Dermatology Physician (CMS: Dermatology) · Dermatology Physician · Kerrville, TX

  • NPI 1679548440
  • Accepts Medicare
  • MIPS 76.2 / 100 · 2023
  • 31 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
712 Hill Country Dr Ste 100
Kerrville, TX 780286166
(830) 890-5181
fax (830) 890-5162
Mailing address
Po Box 1416
San Antonio, TX 782951416

Credentials & registration

NPPES · NUCC
NPI registered
February 2006 — 20 yrs on file
Profile last updated
January 26, 2024
Year of graduation
1995 — 31 yrs since
Specialty taxonomy
207N00000X — NUCC code
State licenses (2)
Texas #M2999 · Indiana #02002212A

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1679548440. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
11,944
Distinct HCPCS
10
Medicare allowed
$641,559
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 3,153 467 $6
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg 2,800 13 $2
99213 Established patient office or other outpatient visit, 20-29 minutes 1,763 1,040 $86
17000 Destruction of precancer skin growth, 1 growth 946 623 $46
11102 Biopsy of related skin growth, first growth 781 626 $85
17110 Destruction of skin growth, 1-14 growths 521 416 $108
0394T High dose rate electronic brachytherapy, external 483 39 $219
11103 Biopsy of related skin growth, each additional growth 434 246 $48
99203 New patient office or other outpatient visit, 30-44 minutes 380 380 $107
77280 Obtaining data needed to develop the optimal radiation treatment, 1 treatment area 372 36 $256

In context: peer comparison

Among 2 peers in Kerrville Dermatology Physician, average services per provider: 603. This provider delivers 20× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,385
Transactions
49
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 16 $348.84
Amgen INC. 5 $166.80
Janssen Biotech, INC. 4 $162.01
Biofrontera INC. 2 $112.37
Merz North America, INC. 4 $109.31
Sun Pharmaceutical Industries INC. 4 $95.64
Arcutis Biotherapeutics, INC. 4 $83.82
Lilly USA, LLC 2 $57.90
Genzyme Corporation 2 $49.47
Ucb, INC. 1 $44.90
Boehringer Ingelheim Pharmaceuticals, INC. 1 $31.97
Incyte Corporation 1 $24.73
Almirall LLC 1 $20.82
Revance Therapeutics, INC. 1 $16.88
E.R. Squibb & Sons, L.L.C. 1 $15.87

By nature of payment

Food and Beverage
$1,290
Education
$95

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
369
Patients
287
Total drug cost
$80,352
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 100 86 $1,194
Clobetasol Propionate Generic 55 36 $4,463
Fluorouracil Generic 38 37 $3,874
Doxycycline Hyclate Generic 35 29 $639
Clotrimazole-Betamethasone (Clotrimazole/Betamethasone Dip) Brand 23 17 $796
Mupirocin Generic 23 21 $227
Metronidazole Generic 22 17 $1,408
Fluocinonide Generic 19 16 $1,440
Cephalexin Generic 16 16 $32
Otezla (Apremilast) Brand 13 0 $65,852

Frequently asked questions

Auto-generated from federal data
What is Dr. Matthew Lambiase's medical specialty?
Dr. Matthew Lambiase practices Dermatology Physician in Kerrville, TX.
Where does Dr. Matthew Lambiase practice?
Dr. Matthew Lambiase practices at 712 Hill Country Dr Ste 100, Kerrville, TX 780286166. Office phone: 8308905181.
What is Dr. Matthew Lambiase's NPI?
Dr. Matthew Lambiase's National Provider Identifier (NPI) is 1679548440, issued by NPPES.
Does Dr. Matthew Lambiase accept Medicare assignment?
Yes. Dr. Matthew Lambiase accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Matthew Lambiase commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.